TP53, the most commonly mutated gene in HNSCC patients, induces cell cycle arrest and apoptosis, and also up-regulates collagen gene expression to inhibit angiogenesis [24,28,29]. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.